Limited seats remaining: Join CEOs, R&D heads, policy makers and investors at Boston CEO, November 2-3

November 2-3, 2026

Mandarin Oriental Hotel, Boston

biopharma CEOs • heads of R&D • investors • policymakers • academics

Boston CEO is two weeks away. Join us for two days of off-the-record discussion and senior-level networking at the Mandarin Oriental, Boston, co-hosted with leaders in the industry: Jane Grogan, Bob Langer, Mathai Mammen, Fiona Marshall, Bill Meury, Robert Plenge, Phil Sharp, David Weinreich, and Christoph Westphal.

Limited seats remain for this not-to-be-missed forum. Register now to secure your spot.

Two panelists laughing, one hand on the other's knee

Reserve your spot now

FEATURED SPEAKERS

BioPharma CEOs

Laurent Levy

CEO

Nanobiotix

Mathai Mammen

CEO

Parabilis

Bill Meury

CEO

Incyte

Jean-Frédéric Paulsen

CEO

Ferring

Tarek Rabah

President & CEO

Otsuka US

Research & Innovation Pioneers

Susan Hockfield

President Emerita

MIT

Bill Kaelin

Nobel laureate

Professor

Dana-Farber Cancer Institute

Bob Langer

MIT

Co-Founder, Moderna

Phil Sharp

Nobelist; MIT

Co-Founder, Alnylam/Biogen

Tim Springer

Lasker, Harvard

Co-Founder,

Moderna/Morphic

R&D Leaders

Jane Grogan

EVP, Head, Research

Biogen

Jeff Legos

Chief Oncology Officer

Pfizer

Fiona Marshall

President, Biomedical Research

Novartis

Robert Plenge

Chief Research Officer

BMS

David Weinreich

Global Head, R&D

EMD Serono

Health System & Advocacy Leaders

Julian Adams

CEO

Stand Up To Cancer

Jake Auchincloss

Congressman

Massachusetts

Julie Gerberding

CEO, FNIH

former Director, CDC

John O'Brien

CEO

National Pharmaceutical Council

Kevin Tabb

CEO

Beth Israel Lahey Health

Pharma BD & Strategy Leaders

Andrew Baum

Senior Strategic Advisor

Pfizer

Matt Hefner

Global Head, BD

Kyowa Kirin

Christine Roth

Head, Global Product Strategy

Bayer Pharma

Tolga Tanguler

CCO

Alnylam

Issei Tsukamoto

SVP, Head, BD

Astellas

Blue-Chip Investors

Ari Brettman

Senior

Managing Director

Blackstone Life Science

Jeanne Cunicelli

President

UPMC Enterprises

Ansbert Gadicke

Managing Partner

MPM BioImpact

Cailin McGurk

Managing Director

Morgan Stanley

Jason Rhodes

Partner

Atlas Venture

See the full speaking faculty

Discussion Topics

Join two days of off-the-record discussion with decision-makers in the industry.

This year’s topics include:

Translating Science into Medicine · Ecosystem of External Innovation · Developing a Robust Pipeline · R&D Collaboration · Competing in a New Global Playing Field · Bolstering the Regulatory Strategy · Capital Formation and Strategic Partnerships · Investor Outlook · Building Global BioPharmas · Drug Approvals: Insights, Outlook, and Commitment to Patients · Crossroads of Science and Policy · Targeted Licensing & Acquisitions · Accelerating Drug Discovery · Positioning for Commercial Success · The Evolving Deal-Making Landscape · Evaluating Investment Risk